Benjamin M.
- Country
- Germany
- Department
- Klinik für Kardiologie, Angiologie, Pneumologie
Research Overview
- A Long-term Safety Extension Study of Mavacamten (MYK-461) in Adults with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICKHCM (MYK-461-006) or EXPLORER-HCM (MYK-461-005) Trials (MAVA-LTE)
- Long-term Safety and Tolerability Evaluation of Aficamten (CK-3773274) in Adults with Symptomatic Hypertrophic Cardiomyopathy: An Open-label Extension Study
- Evaluation of Mavacamten in Adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy: A Randomized, Double-blind, Placebo-controlled Study
Data & Insights
Has run more than one trial at 65 of 165 partner sites.
Specializations
Hypertrophic Cardiomyopathy Research
This investigator specializes in treating hypertrophic cardiomyopathy (HCM), with particular focus on both obstructive and non-obstructive forms of the condition. Their research explores innovative therapeutic approaches using cardiac myosin inhibitors.
- Obstructive HCM management
- Non-obstructive HCM treatment
- Long-term cardiac remodeling assessment
Their work includes evaluation of novel medications like aficamten and mavacamten for symptom improvement and exercise capacity enhancement.
Inflammatory Cardiomyopathy Studies
The investigator conducts research in virus-negative inflammatory cardiomyopathy, focusing on immunosuppressive therapeutic approaches for patients with compromised cardiac function.
- Cardiac function improvement strategies
- Immunosuppressive treatment protocols
- Left ventricular function assessment
Their research encompasses evaluation of targeted therapies for patients with biopsy-proven inflammatory cardiomyopathy resistant to standard treatments.
Genetic Cardiomyopathy Research
The investigator studies genetic forms of dilated cardiomyopathy (DCM), particularly those associated with myosin heavy chain 7 (MYH7) and titin (TTN) variants.
- Gene mutation-specific treatments
- Novel therapeutic approaches
- Safety and tolerability assessments
Their work includes investigation of targeted treatments like danicamtiv for specific genetic variants of DCM.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.